{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:31:49Z","timestamp":1787070709633,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"\n A\n BSTRACT<\/jats:sc>\n <\/jats:title>\n \n Background:<\/jats:title>\n Gestational diabetes mellitus (GDM) increases the maternal and fetal risk, including macrosomia, shoulder dystocia or other birth injuries, premature delivery, and preeclampsia. Diagnosis of GDM in early pregnancy may help to prevent these complications. Our study aims to evaluate the usefulness of glycosylated fibronectin in the prediction of GDM in the first trimester of pregnancy and to compare its level in pregnant women with GDM and without GDM.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n After ethics approval and written informed consent, this prospective, single-centre, cohort study was done on 120 pregnant women. The sample for the analysis of serum glycosylated fibronectin was collected at 7\u201313 weeks of gestation and stored at -180 degrees for further analysis by the Western blot method. We used screening strategies as recommended by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) for the detection of GDM by an oral glucose tolerance test (OGTT) after taking 75 grams of glucose at 24\u201328 weeks of gestation. Out of a total of 120 screened patients, 42 pregnant women by OGTT were diagnosed to have GDM grouped, as cases. A similar number of non-GDM pregnant patients were taken and considered as the control group. Both groups were analyzed for glycosylated fibronectin after getting the result of OGTT between 24\u201328 weeks of pregnancy.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n There were decreased levels of first-trimester maternal serum glycosylated fibronectin in GDM than in non-GDM pregnant women with the area under the receiver operating characteristic (ROC) curve was 72.4% (95% CI: 61.6% to 83.2%.\n P<\/jats:italic>\n value < 0.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n We found decreased levels of first-trimester maternal serum glycosylated fibronectin in GDM than in non-GDM pregnant women. This study proves that the glycosylated fibronectin test is of modest diagnostic accuracy and clinical applicability as an early screening method for the prediction of GDM in the first trimester of pregnancy.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_1842_24","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T10:01:00Z","timestamp":1751277660000},"page":"2484-2489","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Glycosylated fibronectin as a biomarker to predict gestational diabetes mellitus in the first trimester of pregnancy"],"prefix":"10.4103","volume":"14","author":[{"given":"Indu","family":"Lata","sequence":"first","affiliation":[{"name":"Department of Maternal and Reproductive Health, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Kant","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Biotechnology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhaker","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Health Informatics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"R1-20250707","first-page":"827","article-title":"Gestational diabetes mellitus: Major risk factors and pregnancy-related outcomes: A cohort study","volume":"19","author":"Kouhkan","year":"2021","journal-title":"Int J Reprod Biomed"},{"key":"R2-20250707","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4093\/dmj.2021.0335","article-title":"Gestational diabetes mellitus: Diagnostic approaches and maternal-offspring complications","volume":"46","author":"Moon","year":"2022","journal-title":"Diabetes Metab J"},{"key":"R3-20250707","doi-asserted-by":"crossref","first-page":"109050","DOI":"10.1016\/j.diabres.2021.109050","article-title":"IDF Diabetes Atlas Committee Hyperglycaemia in Pregnancy Special Interest Group. IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group's Criteria","volume":"183","author":"Wang","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"R4-20250707","doi-asserted-by":"crossref","first-page":"108642","DOI":"10.1016\/j.diabres.2020.108642","article-title":"Increasing prevalence of gestational diabetes mellitus when implementing the IADPSG criteria: A systematic review and meta-analysis","volume":"172","author":"Saeedi","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"R5-20250707","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3390\/medicina57090942","article-title":"Negotiating gestational diabetes mellitus in India: A national approach","volume":"57","author":"Thanawala","year":"2021","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"R6-20250707","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ogc.2017.02.002","article-title":"Gestational diabetes: Diagnosis, classification, and clinical care","volume":"44","author":"Mack","year":"2017","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R7-20250707","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/AOG.0b013e3182a0c88b","article-title":"Glycosylated fibronectin as a first-trimester biomarker for prediction of gestational diabetes","volume":"122","author":"Rasanen","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R8-20250707","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s00125-015-3855-6","article-title":"Accuracy of circulating adiponectin for predicting gestational diabetes: A systematic review and meta-analysis","volume":"59","author":"Iliodromiti","year":"2016","journal-title":"Diabetologia"},{"key":"R9-20250707","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1900\/RDS.2016.13.236","article-title":"First-trimester maternal serum amino acids and acylcarnitines are significant predictors of gestational diabetes","volume":"13","author":"Nevalainen","year":"2016","journal-title":"Rev Diabet Stud"},{"key":"R10-20250707","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.metabol.2015.10.029","article-title":"First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation","volume":"65","author":"Syngelaki","year":"2016","journal-title":"Metabolism"},{"key":"R11-20250707","doi-asserted-by":"crossref","first-page":"691033","DOI":"10.3389\/fendo.2021.691033","article-title":"Gestational diabetes mellitus in Europe: A systematic review and meta-analysis of prevalence studies","volume":"12","author":"Paulo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R12-20250707","first-page":"398","article-title":"Changing diagnostic criteria for gestational diabetes in Sweden-a stepped wedge national cluster randomised controlled trial-the CDC4G study protocol","volume":"19","author":"Fadl","year":"2019","journal-title":"BMC PregnancyChildbirth"},{"key":"R13-20250707","doi-asserted-by":"crossref","first-page":"e067946","DOI":"10.1136\/bmj-2021-067946","article-title":"Gestational diabetes mellitus and adverse pregnancy outcomes: Systematic review and meta-analysis","volume":"377","author":"Ye","year":"2022","journal-title":"BMJ"},{"key":"R14-20250707","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2214956","article-title":"Treatment of gestational diabetes mellitus diagnosed early in pregnancy","volume":"388","author":"Simmons","year":"2023","journal-title":"N Engl J Med"},{"key":"R15-20250707","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc18-1646","article-title":"Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal gestational diabetes mellitus and childhood glucose metabolism","volume":"42","author":"Lowe","year":"2019","journal-title":"Diabetes Care"},{"key":"R16-20250707","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/2230-8210.140226","article-title":"Maternal serum biomarkers for risk assessment in gestational diabetes. A potential universal screening test to predict GDM status","volume":"19","author":"Nagalla","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"R17-20250707","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00404-020-05670-8","article-title":"Glycosylated fibronectin as a first-trimester marker for gestational diabetes","volume":"302","author":"Alanen","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"R18-20250707","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12884-024-06651-4","article-title":"Prediction of gestational diabetes mellitus by multiple biomarkers at early gestation","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"R19-20250707","doi-asserted-by":"crossref","first-page":"e012115","DOI":"10.1136\/bmjopen-2016-012115","article-title":"Screening of gestational diabetes mellitus in early pregnancy by oral glucose tolerance test and glycosylated fibronectin: Study protocol for an international, prospective, multicentre cohort trial","volume":"6","author":"Huhn","year":"2016","journal-title":"BMJ Open"},{"key":"R20-20250707","first-page":"1399694","article-title":"Genetic and inflammatory factors underlying gestational diabetes mellitus: A review","volume":"15","author":"Ray","year":"2024","journal-title":"FrontEndocrinol"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1842_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:35:11Z","timestamp":1787067311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1842_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1842_24","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"2024-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}